We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $97.9B
1-Year Est. Return 20.73%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+20.73%
3 Year Est. Return
+127.31%
5 Year Est. Return
+136.48%
10 Year Est. Return
+1,577.48%
AUM
$56.1B
AUM Growth
-$763M
Cap. Flow
-$290M
Cap. Flow %
-0.52%
Top 10 Hldgs %
48.8%
Holding
206
New
9
Increased
66
Reduced
73
Closed
13

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$259M
2
BABA icon
Alibaba
BABA
+$250M
3
UAA icon
Under Armour
UAA
+$195M
4
WAB icon
Wabtec
WAB
+$192M
5
IBKR icon
Interactive Brokers
IBKR
+$174M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
LNKD
LinkedIn Corporation
LNKD
+$312M
3
HAPN
Happen Inc
HAPN
+$287M
4
QCOM icon
Qualcomm
QCOM
+$244M
5
PX
Praxair Inc
PX
+$239M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.88%
2 Communication Services 19.56%
3 Healthcare 12.38%
4 Financials 9.29%
5 Technology 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
176
Protalix BioTherapeutics
PLX
$191M
$4.07M 0.01%
636,136
-4,474
-0.7% -$35.8K
POWI icon
177
Power Integrations
POWI
$3.38B
$4.04M 0.01%
161,360
SKM icon
178
SK Telecom
SKM
$12.1B
$3.91M 0.01%
113,554
+18,635
+20% +$614K
REGN icon
179
Regeneron Pharmaceuticals
REGN
$78.5B
$3.53M 0.01%
10,100
ADAP
180
DELISTED
Adaptimmune Therapeutics
ADAP
$3.5M 0.01%
429,700
KDNY
181
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.28M 0.01%
58,000
+12,000
+26% +$729K
FMI
182
DELISTED
Foundation Medicine, Inc.
FMI
$3.26M 0.01%
174,800
ARMH
183
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$3.25M 0.01%
71,451
WIT icon
184
Wipro
WIT
$19.6B
$3.05M 0.01%
1,315,131
-1,362,720
-51% -$3.11M
RIO icon
185
Rio Tinto
RIO
$158B
$2.21M ﹤0.01%
70,626
ONC
186
BeOne Medicines Ltd
ONC
$32.8B
$2.03M ﹤0.01%
68,200
+66,350
+3,586% +$1.95M
HCM icon
187
HUTCHMED
HCM
$1.93B
$1.97M ﹤0.01%
+149,810
New +$1.98M
BIOA
188
DELISTED
BioAmber Inc.
BIOA
$1.73M ﹤0.01%
579,540
ACTG icon
189
Acacia Research
ACTG
$428M
$1.61M ﹤0.01%
365,820
LXFT
190
DELISTED
Luxoft Holding, Inc.
LXFT
$1.48M ﹤0.01%
+28,430
New +$1.66M
FOMX
191
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.39M ﹤0.01%
219,400
VALE.P
192
DELISTED
Vale S A
VALE.P
$1.29M ﹤0.01%
323,000
SNMX
193
DELISTED
Senomyx, Inc.
SNMX
$334K ﹤0.01%
121,665
-456,335
-79% -$1.22M
BRK.B icon
194
Berkshire Hathaway Class B
BRK.B
$1.1T
-41,243
Closed -$5.85M
EBAY icon
195
eBay
EBAY
$50.6B
-8,814,111
Closed -$210M
EFA icon
196
iShares MSCI EAFE ETF
EFA
$78B
-10,868
Closed -$621K
EHC icon
197
Encompass Health
EHC
$11B
-9,151
Closed -$15K
ETSY icon
198
Etsy
ETSY
$7.75B
-485,000
Closed -$4.22M
IWF icon
199
iShares Russell 1000 Growth ETF
IWF
$121B
-591,452
Closed -$14.8M
HAPN
200
Happen Inc
HAPN
$2.21B
-6,924,099
Closed -$287M

Similar funds

Baillie Gifford & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Baillie Gifford & Co held 206 positions worth $56.1B, down 1.3% from $56.8B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Baillie Gifford & Co's Q2 2016 filing shows 9 new, 66 increased, 73 reduced and 13 closed positions. Its largest new stake was China Biologic Products Holdings, Inc.: 1,460,752 shares worth $155M. The largest sale was Amazon, an estimated $353M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.

  • Baillie Gifford & Co's largest Q2 2016 buy was China Biologic Products Holdings, Inc.: 1,460,752 shares worth $155M.
  • Baillie Gifford & Co added most to Tesla in Q2 2016, an estimated $259M increase.
  • Baillie Gifford & Co's biggest Q2 2016 reduction was Amazon, cutting an estimated $353M.
  • Baillie Gifford & Co fully exited Happen Inc in Q2 2016, selling an estimated $287M.
  • Baillie Gifford & Co's ten largest holdings make up 49% of its $56.1B portfolio in Q2 2016.
  • Baillie Gifford & Co opened 9 new positions and closed 13 in Q2 2016.
  • Baillie Gifford & Co's portfolio value fell 1.3% quarter-over-quarter to $56.1B.

Based on Baillie Gifford & Co's 13F filing for Q2 2016, filed 9 Aug 2016.